1 for Agranulocytosis secondary to cancer chemotherapy is a medical classification as listed by WHO under the range - Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism .
Congenital agranulocytosis (Kostmann's Syndrome) is a rare autosomal recessive inherited disorder characterised by severe neutropenia, recurrent infections, and death in early life, with the bone marrow showing a maturation arrenst of myeloid cells at the myelocyte stage.
ICD-10 code Z51. 11 for Encounter for antineoplastic chemotherapy is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
Genetic susceptibility to other disease Z15. 89 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM Z15. 89 became effective on October 1, 2021.
There are two types of agranulocytosis: acquired or congenital. Acquired agranulocytosis means that a person develops the condition, whereas congenital agranulocytosis means that a person is born with the condition. Certain conditions or medications that affect the immune system can cause acquired agranulocytosis.
Also known as granulocytopenia, agranulocytosis is a severe form of neutropenia. Neutropenia is lower-than-normal levels of white blood cells.
Encounter for antineoplastic immunotherapyICD-10 code Z51. 12 for Encounter for antineoplastic immunotherapy is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
11 or Z51. 12 is the only diagnosis on the line, then the procedure or service will be denied because this diagnosis should be assigned as a secondary diagnosis. When the Primary, First-Listed, Principal or Only diagnosis code is a Sequela diagnosis code, then the claim line will be denied.
Most pre-op exams will be coded with Z01. 818. The ICD-10 instructions say to use the preprocedural diagnosis code first, and then the reason for the surgery and any additional findings. Evaluations before surgery are reimbursable services.
ICD-10 code Z13. 79 for Encounter for other screening for genetic and chromosomal anomalies is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
Chromosomal abnormality, unspecified Q99. 9 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM Q99. 9 became effective on October 1, 2021.
ICD-10 Code for Family history of carrier of genetic disease- Z84. 81- Codify by AAPC. Factors influencing health status and contact with health services. Persons with potential health hazards related to family and personal history and certain conditions influencing health status.
Kostmann syndrome is a group of diseases that affect myelopoiesis, causing a congenital form of neutropenia (severe congenital neutropenia [SCN]), usually without other physical malformations. SCN manifests in infancy with life-threatening bacterial infections.
Inclusion Terms are a list of concepts for which a specific code is used. The list of Inclusion Terms is useful for determining the correct code in some cases, but the list is not necessarily exhaustive.
DRG Group #808-810 - Major hematol or immun diagnoses except sickle cell crisis and coagul with MCC.
The ICD-10-CM Alphabetical Index links the below-listed medical terms to the ICD code D70.0. Click on any term below to browse the alphabetical index.
This is the official exact match mapping between ICD9 and ICD10, as provided by the General Equivalency mapping crosswalk. This means that in all cases where the ICD9 code 288.01 was previously used, D70.0 is the appropriate modern ICD10 code.